Search all trials

Find therapies in clinical trials near you – page 44

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Netherton's syndrome

Not recruiting

Investigational

Study to Evaluate the Effectiveness of Spesolimab in Treating Patients with Netherton Syndrome

Investigational

Finland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Registered drug

Finland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Finland

Participants:18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Not recruiting

Registered drug

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Ischaemic stroke

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Tenecteplase

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational

Finland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Upadacitinib

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Finland

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

Generalised anxiety disorder

Not recruiting

Investigational

Study on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder

Investigational

Finland

Participants:18–64 years · 65+ years
Substances:Ulotaront

Contact Research Centre

Find therapies in clinical trials near you – page 44

551 trials match your criteria

Netherton's syndrome

Study to Evaluate the Effectiveness of Spesolimab in Treating Patients with Netherton Syndrome

Breast cancer

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Malignant melanoma

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Hidradenitis

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Neoplasm malignant

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Ischaemic stroke

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Bladder cancer

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Dermatitis atopic

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Generalised anxiety disorder

Study on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.